Navigation Links
US Pharmacopeia partners with Quantros to enhance the MEDMARX patient safety reporting program
Date:12/6/2007

Rockville, Md., December 6, 2007 The U.S. Pharmacopeia (USP) has formed a strategic alliance with Quantros, a health care information management technology provider, to enhance MEDMARX, USPs premier adverse drug event reporting program. The more robust database resulting from this alliance will provide USP and users of MEDMARX access to larger data sets from more U.S. hospitals and health systems for the identification and prevention of medication errors and adverse drug events. The MEDMARX database currently draws from more than 400 hospitals and healthcare systems and is the largest medication error database in the world.

Under this arrangement, Quantros will manage the operations of the MEDMARX system, including marketing, sales and client support. This will enable USP to continue its focus, even more intently, on data analysis, research, standards-setting and dissemination of safe practices that will help practitioners prevent errors.

Quantros and USPs patient safety efforts are complementary, said Roger L. Williams, M.D., executive vice president and CEO of USP. The two organizations share a commitment to reducing medication errors and improving public health. This partnership will provide customers with the best of each organizations strengthsclinical technology management from Quantros, and data analysis, research, standards-setting and reporting from USP.

We look forward to providing MEDMARX subscribers with an even more robust database that can reveal to health care providers additional valuable patient safety information, said Sanjaya Kumar, M.D., president and CEO of Quantros.

The USP/Quantros partnership takes effect Jan. 1, 2008.


'/>"/>

Contact: Sandra Kim
sek@usp.org
301-816-8241
US Pharmacopeia
Source:Eurekalert

Page: 1

Related medicine news :

1. Pharmacopeia Announces Senior Additions to Management Team
2. Pharmacopeia Acquires Selective Androgen Receptor Modulator (SARM) Program from Bristol-Myers Squibb
3. Pharmacopeia and GlaxoSmithKline Collaboration Identifies Two Additional Lead Compounds
4. AtriCure to Present at Thomas Weisel Partners 2007 Healthcare Conference
5. Matrixx Initiatives, Inc. to Present at the Roth Capital Partners 2007 New York Conference
6. ATS Medical to Present at the 2007 Thomas Weisel Partners Healthcare Conference
7. Thailand: Partners Open Free AIDS Treatment Clinic in Renowned AIDS Temple in Lop Buri
8. AtriCure to Present at Roth Capital Partners 2007 New York Conference
9. MDS to Present at Thomas Weisel Partners Healthcare Conference
10. Lutheran Senior Services Partners with Silverchair Learning Systems to Enhance Employee Training and Education
11. AMICAS to Present at Thomas Weisel Partners Healthcare Conference 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2017)... New York (PRWEB) , ... May 23, 2017 ... ... NextGen LifeLabs, a leading equipment provider in the modern ART laboratory, to provide ... Institute in Ft. Lauderdale, Florida. , NextGen LifeLabs, a MedTech Group Purchasing ...
(Date:5/23/2017)... MA (PRWEB) , ... May 23, 2017 , ... Orbita’s ... on Tuesday, May 23, 2017 in San Francisco. Titled Connected Health and IoT: ... Connected Home Event hosted by Parks Associates, a market research and consulting firm ...
(Date:5/23/2017)... San Francisco, California (PRWEB) , ... May 23, 2017 , ... ... released results of its new survey in an infographic on the current state of ... 900 U.S. respondents, familiar with anxiety, was conducted in April 2017 and benchmarked general ...
(Date:5/22/2017)... Kisco, NY (PRWEB) , ... May 22, 2017 , ... ... are urged to receive relaxing sedation dentistry in Mt. Kisco, NY from Advanced Endodontics ... be administered for a variety of treatments. One or more sedation methods may be ...
(Date:5/22/2017)... ... May 22, 2017 , ... An inventor from Columbia, S.C., ... pen. "My wife’s hand was damaged in a firework accident, so she couldn’t grip ... with manual problems." , He then designed and created a prototype for the HELPEN ...
Breaking Medicine News(10 mins):
(Date:5/15/2017)... PHILADELPHIA , May 15, 2017 Enterin Inc., ... and developing novel compounds to treat Parkinson,s disease ... The study is a Phase 1/2a randomized, controlled, multicenter study ... sites. It will enroll 50 patients over a 9-to-12-month period. ... doses in 10 patients with PD. Participating sites include ...
(Date:5/10/2017)...  The Corporate Whistleblower Center says, "We are ... clinics to call us anytime at 866-714-6466 if they ... in a substantial scheme to overbill Medicare. We ... employee of a medical equipment company if their ... medical practice groups with extra generous incentives to use, ...
(Date:5/9/2017)... , May 9, 2017  Oramed Pharmaceuticals Inc. ... a clinical-stage pharmaceutical company focused on the development ... the Canadian Intellectual Property Office has granted Oramed ... Administration of Exenatide". The patent covers Oramed,s invention ... GLP-1 is an incretin hormone that stimulates ...
Breaking Medicine Technology: